See more : Informa plc (INF.L) Income Statement Analysis – Financial Results
Complete financial analysis of Rite Aid Corporation (RAD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rite Aid Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Dragonfly Energy Holdings Corp. (DFLIW) Income Statement Analysis – Financial Results
- Sierra Rutile Holdings Limited (SRX.AX) Income Statement Analysis – Financial Results
- CP ALL Public Company Limited (CVPBF) Income Statement Analysis – Financial Results
- ZHEJIANG DRAGON TECHNOLOGY CO L (603004.SS) Income Statement Analysis – Financial Results
- Fast Radius, Inc. (FSRDW) Income Statement Analysis – Financial Results
Rite Aid Corporation (RAD)
About Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.09B | 24.57B | 24.04B | 21.93B | 21.64B | 21.53B | 22.93B | 30.74B | 26.53B | 25.53B | 25.39B | 26.12B | 25.21B | 25.67B | 26.29B | 24.33B | 17.51B | 17.27B | 16.82B | 16.60B | 15.80B | 15.17B | 14.52B | 14.68B | 12.73B | 11.38B | 6.97B | 5.45B | 4.53B | 4.06B | 4.09B | 3.75B | 3.45B | 3.17B | 2.87B | 2.49B | 1.76B | 1.56B |
| Cost of Revenue | 19.29B | 19.46B | 19.34B | 17.20B | 16.96B | 16.75B | 17.86B | 22.91B | 18.95B | 18.20B | 18.07B | 19.33B | 18.52B | 18.85B | 19.25B | 17.69B | 12.79B | 12.57B | 12.61B | 12.57B | 12.11B | 11.74B | 10.77B | 10.97B | 9.14B | 8.02B | 4.94B | 3.90B | 3.23B | 2.87B | 2.89B | 2.63B | 2.39B | 2.20B | 1.98B | 1.73B | 1.21B | 1.08B |
| Gross Profit | 4.80B | 5.11B | 4.70B | 4.73B | 4.68B | 4.78B | 5.06B | 7.83B | 7.58B | 7.32B | 7.32B | 6.79B | 6.69B | 6.82B | 7.04B | 6.64B | 4.72B | 4.70B | 4.21B | 4.03B | 3.69B | 3.43B | 3.75B | 3.71B | 3.59B | 3.36B | 2.03B | 1.55B | 1.30B | 1.18B | 1.19B | 1.12B | 1.05B | 973.00M | 885.00M | 756.30M | 546.80M | 485.50M |
| Gross Profit Ratio | 19.94% | 20.78% | 19.57% | 21.56% | 21.61% | 22.20% | 22.09% | 25.46% | 28.56% | 28.69% | 28.82% | 26.01% | 26.54% | 26.58% | 26.76% | 27.28% | 26.94% | 27.21% | 25.02% | 24.29% | 23.36% | 22.60% | 25.83% | 25.29% | 28.23% | 29.52% | 29.06% | 28.41% | 28.77% | 29.18% | 29.22% | 29.83% | 30.55% | 30.67% | 30.85% | 30.42% | 31.13% | 31.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.60B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 3.37B | 3.46B | 3.71B | 2.64B | 2.39B | 1.43B | 1.10B | 932.20M | 1.01B | 847.70M | 781.90M | 732.90M | 700.10M | 613.60M | 506.50M | 346.60M | 304.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 483.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 352.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.58B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 4.20B | 4.65B | 4.21B | 2.94B | 2.67B | 1.60B | 1.22B | 1.03B | 1.11B | 946.00M | 875.40M | 826.20M | 784.50M | 690.40M | 567.50M | 390.90M | 341.70M |
| Cost & Expenses | 24.19B | 24.50B | 24.00B | 21.79B | 21.56B | 21.40B | 22.64B | 29.92B | 25.65B | 24.76B | 24.67B | 25.86B | 24.98B | 25.43B | 26.24B | 24.06B | 17.16B | 16.88B | 16.37B | 16.22B | 15.52B | 15.94B | 15.42B | 15.18B | 12.08B | 10.69B | 6.55B | 5.12B | 4.26B | 3.98B | 3.84B | 3.51B | 3.22B | 2.98B | 2.67B | 2.30B | 1.60B | 1.42B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M | 202.77M | 200.07M | 449.57M | 397.61M | 424.59M | 515.42M | 529.26M | 547.58M | 515.76M | 477.63M | 449.60M | 275.22M | 277.02M | 294.87M | 313.50M | 396.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M | 386.06M | 407.37M | 509.21M | 416.63M | 403.74M | 414.11M | 440.58M | 505.55M | 534.24M | 586.21M | 472.47M | 270.31M | 249.76M | 246.74M | 264.29M | 285.33M | 349.84M | 384.07M | 501.00M | 302.60M | 274.20M | 168.10M | 118.70M | 98.60M | 95.70M | 98.30M | 93.50M | 93.30M | 84.40M | 76.80M | 61.00M | 44.30M | 37.20M |
| EBITDA | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M | 514.90M | 695.08M | 1.32B | 1.30B | 1.17B | 1.45B | 702.51M | 762.44M | 778.10M | -2.91B | -1.08B | 834.33M | 918.46M | 718.57M | 686.98M | 681.40M | -17.56M | -11.40M | 95.52M | 1.21B | 964.00M | 659.70M | 443.20M | 372.40M | 170.10M | 345.90M | 336.30M | 320.40M | 272.90M | 268.30M | 247.40M | 195.40M | 177.00M |
| EBITDA Ratio | 0.74% | 1.50% | 1.56% | 2.13% | 2.04% | 2.39% | 3.03% | 4.30% | 4.89% | 4.57% | 4.46% | 2.69% | 3.02% | 3.03% | 10.62% | 3.45% | 3.84% | 4.13% | 4.27% | 4.14% | 4.31% | -0.12% | -0.08% | 0.65% | 9.52% | 8.47% | 9.46% | 8.14% | 8.21% | 4.19% | 8.47% | 8.97% | 9.29% | 8.60% | 9.35% | 9.95% | 11.12% | 11.32% |
| Operating Income | -98.15M | 72.62M | 47.14M | 139.42M | 83.98M | 128.84M | 287.71M | 812.91M | 881.09M | 762.57M | 717.51M | 261.92M | 256.90M | 243.86M | 2.21B | 366.78M | 402.48M | 463.10M | 471.83M | 422.69M | 396.07M | -367.40M | -395.47M | -405.47M | 909.00M | 689.80M | 491.60M | 324.50M | 273.80M | 74.40M | 247.60M | 242.80M | 227.10M | 188.50M | 191.50M | 186.40M | 151.10M | 139.80M |
| Operating Income Ratio | -0.41% | 0.30% | 0.20% | 0.64% | 0.39% | 0.60% | 1.25% | 2.64% | 3.32% | 2.99% | 2.83% | 1.00% | 1.02% | 0.95% | 8.39% | 1.51% | 2.30% | 2.68% | 2.81% | 2.55% | 2.51% | -2.42% | -2.72% | -2.76% | 7.14% | 6.06% | 7.05% | 5.96% | 6.04% | 1.83% | 6.06% | 6.48% | 6.59% | 5.94% | 6.68% | 7.50% | 8.60% | 8.94% |
| Total Other Income/Expenses | -658.26M | -614.88M | -20.16M | -221.03M | -673.45M | -172.39M | -239.19M | -534.51M | -454.27M | -512.35M | -710.01M | -261.89M | 9.84M | 26.76M | -2.63B | -544.94M | -388.90M | -419.85M | -168.47M | -403.12M | -167.64M | -405.44M | -887.34M | -710.27M | -709.40M | -159.80M | -164.60M | -68.30M | -42.30M | -28.70M | -33.00M | -40.80M | -52.40M | -54.70M | -40.30M | -32.20M | -18.10M | -11.90M |
| Income Before Tax | -756.40M | -542.26M | -120.23M | -81.61M | -589.48M | -43.55M | 48.52M | 278.40M | 426.82M | 250.22M | 7.51M | -392.26M | -545.58M | -479.92M | -2.58B | -273.50M | 13.58M | 43.25M | 134.01M | 34.52M | -167.64M | -772.84M | -1.28B | -1.12B | 199.60M | 530.00M | 258.90M | 256.20M | 231.50M | 45.70M | 214.60M | 202.00M | 174.70M | 133.80M | 154.30M | 156.60M | 137.80M | 127.90M |
| Income Before Tax Ratio | -3.14% | -2.21% | -0.50% | -0.37% | -2.72% | -0.20% | 0.21% | 0.91% | 1.61% | 0.98% | 0.03% | -1.50% | -2.16% | -1.87% | -9.82% | -1.12% | 0.08% | 0.25% | 0.80% | 0.21% | -1.06% | -5.09% | -8.84% | -7.60% | 1.57% | 4.66% | 3.71% | 4.70% | 5.11% | 1.13% | 5.25% | 5.39% | 5.07% | 4.22% | 5.38% | 6.30% | 7.84% | 8.18% |
| Income Tax Expense | -6.47M | -3.78M | -20.16M | 387.61M | 77.48M | 305.99M | 44.44M | 112.94M | -1.68B | 804.00K | -110.60M | -23.69M | 9.84M | 26.76M | 329.26M | 802.70M | -13.24M | -1.23B | -168.47M | -48.80M | -41.94M | -11.75M | 148.96M | 8.00K | 55.90M | 213.60M | 98.40M | 97.30M | 90.20M | 19.50M | 82.20M | 78.00M | 67.40M | 51.90M | 59.10M | 62.80M | 59.80M | 60.00M |
| Net Income | -749.94M | -538.48M | -100.07M | -469.22M | -422.21M | 943.47M | 4.05M | 165.47M | 2.11B | 249.41M | 118.11M | -368.57M | -555.42M | -506.68M | -2.92B | -1.08B | 26.83M | 1.27B | 302.48M | 83.31M | -112.08M | -827.68M | -1.59B | -1.14B | 143.70M | 316.40M | 115.30M | 158.90M | 141.30M | 9.30M | 132.40M | 124.00M | 107.30M | 102.10M | 95.20M | 140.90M | 78.00M | 62.50M |
| Net Income Ratio | -3.11% | -2.19% | -0.42% | -2.14% | -1.95% | 4.38% | 0.02% | 0.54% | 7.95% | 0.98% | 0.47% | -1.41% | -2.20% | -1.97% | -11.09% | -4.44% | 0.15% | 7.37% | 1.80% | 0.50% | -0.71% | -5.46% | -10.95% | -7.79% | 1.13% | 2.78% | 1.65% | 2.92% | 3.12% | 0.23% | 3.24% | 3.31% | 3.11% | 3.22% | 3.32% | 5.67% | 4.44% | 4.00% |
| EPS | -13.71 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 43.40 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 47.20 | 10.05 | 2.27 | -4.34 | -35.03 | -111.20 | -88.19 | -35.80 | -14.80 | 6.30 | 9.50 | 16.70 | 0.90 | 7.50 | 7.10 | 3.25 | 3.10 | 2.85 | 4.30 | 2.40 | 1.90 |
| EPS Diluted | -13.64 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 41.60 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 37.80 | 8.25 | 2.23 | -4.34 | -35.03 | -95.73 | -88.19 | -35.80 | -14.80 | 6.30 | 9.20 | 16.70 | 0.90 | 7.30 | 7.00 | 3.25 | 3.05 | 2.85 | 4.30 | 2.40 | 1.90 |
| Weighted Avg Shares Out | 54.68M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 52.22M | 51.22M | 48.56M | 46.11M | 44.48M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 26.20M | 26.98M | 20.67M | 25.85M | 23.62M | 14.29M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
| Weighted Avg Shares Out (Dil) | 54.99M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 53.04M | 52.12M | 50.89M | 48.95M | 45.36M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 33.83M | 31.70M | 26.29M | 25.85M | 23.62M | 16.60M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced it has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the Company...
Rite Aid files for bankruptcy, will close more stores: report
Drugstore chain Rite Aid Corp. has filed for bankruptcy, the Wall Street Journal reported Sunday night.
Drug retailer Rite Aid files for bankruptcy protection
Rite Aid Corp filed for Chapter 11 bankruptcy on Sunday, as it comes under pressure from lawsuits alleging that the drugstore chain helped fuel the opioid crisis in the United States.
CORRECTING and REPLACING Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
PHILADELPHIA--(BUSINESS WIRE)--Please replace the release dated October 10, 2023, with the following corrected version due to multiple revisions. The updated release reads: CREEP IT SIMPLE: RITE AID RELEASES DIY HALLOWEEN COSTUME RECIPE CARDS Beat the Halloween Hurries by Turning Drug...
Penny Stocks To Buy Now? 8 To Watch With Unusual Options Action
Penny stocks, defined as equities under $5 per share, offer huge upside potential but also higher risk. Savvy traders look for signals from options activity to identify promising penny stocks poised for gains.
5 Penny Stocks To Buy For Under $5 With Unusual Options Action
If you're looking for penny stocks to buy today, broad stock market news might not be at the top of your mind. However, whether focusing on small cap stocks or larger cap stocks, things like today's PPI inflation data report...
Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
PHILADELPHIA--(BUSINESS WIRE)--Each year, Halloween has a way of creeping up, bringing along the annual fear of finding the perfect costume. This season, Rite Aid (NYSE: RAD) is taking away that stress with their Costume Recipe Cards – easy solutions to...
Rite Aid Helps Families Prep for Fall the Rite Way with Family Immunization Day
PHILADELPHIA--(BUSINESS WIRE)--Fall's arrival brings both the bustling return to routine and the unwelcome beginning of respiratory illness season, but getting vaccinated can be a seamless family affair. Rite Aid (NYSE: RAD) will offer a Family Immunization Day at select stores...
Embattled Rite Aid Faces Delisting From NYSE
Rite Aid disclosed it was no longer in compliance with New York Stock Exchange ‘continued listing standards” and needs to take measures to boost its share price to regain good standing.
Rite Aid gets listing warning from NYSE
Shares of Rite Aid Corp. fell 2% after hours on Wednesday after the drugstore chain said the New York Stock Exchange notified the company that it is “no longer in compliance” with the exchange's minimum pricing and valuation standards, following...
Source: https://incomestatements.info
Category: Stock Reports